Severe acute respiratory syndrome: pertinent clinical characteristics and therapy.
Identifieur interne : 004627 ( Main/Exploration ); précédent : 004626; suivant : 004628Severe acute respiratory syndrome: pertinent clinical characteristics and therapy.
Auteurs : Thomas M. File [États-Unis] ; Kenneth W T. TsangSource :
- Treatments in respiratory medicine [ 1176-3450 ] ; 2005.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Syndrome respiratoire aigu sévère.
- épidémiologie : Syndrome respiratoire aigu sévère.
- Algorithmes, Humains, Lutte contre l'infection, Syndrome respiratoire aigu sévère.
English descriptors
- KwdEn :
- MESH :
- diagnosis : Severe Acute Respiratory Syndrome.
- epidemiology : Severe Acute Respiratory Syndrome.
- therapy : Severe Acute Respiratory Syndrome.
- transmission : Severe Acute Respiratory Syndrome.
- Algorithms, Humans, Infection Control.
Abstract
Severe acute respiratory syndrome (SARS) is a newly emerged infection that is caused by a previously unrecognized virus - a novel coronavirus designated as SARS-associated coronavirus (SARS-CoV). From November 2002 to July 2003 the cumulative number of worldwide cases was >8000, with a mortality rate of close to 10%. The mortality has been higher in older patients and those with co-morbidities. SARS has been defined using clinical and epidemiological criteria and cases are considered laboratory-confirmed if SARS coronavirus is isolated, if antibody to SARS coronavirus is detected, or a polymerase chain reaction test by appropriate criteria is positive. At the time of writing (24 May 2004), no specific therapy has been recommended. A variety of treatments have been attempted, but there are no controlled data. Most patients have been treated throughout the illness with broad-spectrum antimicrobials, supplemental oxygen, intravenous fluids, and other supportive measures. Transmission of SARS is facilitated by close contact with patients with symptomatic infection. The majority of cases have been reported among healthcare providers and family members of SARS patients. Since SARS-CoV is contagious, measures for prevention center on avoidance of exposure, and infection control strategies for suspected cases and contacts. This includes standard precautions (hand hygiene), contact precautions (gowns, goggles, gloves) and airborne precautions (negative pressure rooms and high efficiency masks). In light of reports of new cases identified during the winter of 2003-4 in China, it seems possible that SARS will be an important cause of pneumonia in the future, and the screening of outpatients at risk for SARS may become part of the pneumonia evaluation.
DOI: 10.2165/00151829-200504020-00003
PubMed: 15813661
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002803
- to stream PubMed, to step Curation: 002803
- to stream PubMed, to step Checkpoint: 002481
- to stream Ncbi, to step Merge: 000E80
- to stream Ncbi, to step Curation: 000E80
- to stream Ncbi, to step Checkpoint: 000E80
- to stream Main, to step Merge: 004886
- to stream Main, to step Curation: 004627
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Severe acute respiratory syndrome: pertinent clinical characteristics and therapy.</title><author><name sortKey="File, Thomas M" sort="File, Thomas M" uniqKey="File T" first="Thomas M" last="File">Thomas M. File</name><affiliation wicri:level="2"><nlm:affiliation>Northeastern Ohio Universities College of Medicine, Rootstown, Ohio, USA. filet@summa-health.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Northeastern Ohio Universities College of Medicine, Rootstown, Ohio</wicri:regionArea><placeName><region type="state">Ohio</region></placeName></affiliation></author><author><name sortKey="Tsang, Kenneth W T" sort="Tsang, Kenneth W T" uniqKey="Tsang K" first="Kenneth W T" last="Tsang">Kenneth W T. Tsang</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15813661</idno><idno type="pmid">15813661</idno><idno type="doi">10.2165/00151829-200504020-00003</idno><idno type="wicri:Area/PubMed/Corpus">002803</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002803</idno><idno type="wicri:Area/PubMed/Curation">002803</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002803</idno><idno type="wicri:Area/PubMed/Checkpoint">002481</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002481</idno><idno type="wicri:Area/Ncbi/Merge">000E80</idno><idno type="wicri:Area/Ncbi/Curation">000E80</idno><idno type="wicri:Area/Ncbi/Checkpoint">000E80</idno><idno type="wicri:doubleKey">1176-3450:2005:File T:severe:acute:respiratory</idno><idno type="wicri:Area/Main/Merge">004886</idno><idno type="wicri:Area/Main/Curation">004627</idno><idno type="wicri:Area/Main/Exploration">004627</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Severe acute respiratory syndrome: pertinent clinical characteristics and therapy.</title><author><name sortKey="File, Thomas M" sort="File, Thomas M" uniqKey="File T" first="Thomas M" last="File">Thomas M. File</name><affiliation wicri:level="2"><nlm:affiliation>Northeastern Ohio Universities College of Medicine, Rootstown, Ohio, USA. filet@summa-health.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Northeastern Ohio Universities College of Medicine, Rootstown, Ohio</wicri:regionArea><placeName><region type="state">Ohio</region></placeName></affiliation></author><author><name sortKey="Tsang, Kenneth W T" sort="Tsang, Kenneth W T" uniqKey="Tsang K" first="Kenneth W T" last="Tsang">Kenneth W T. Tsang</name></author></analytic><series><title level="j">Treatments in respiratory medicine</title><idno type="ISSN">1176-3450</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Algorithms</term><term>Humans</term><term>Infection Control</term><term>Severe Acute Respiratory Syndrome (diagnosis)</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (therapy)</term><term>Severe Acute Respiratory Syndrome (transmission)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Algorithmes</term><term>Humains</term><term>Lutte contre l'infection</term><term>Syndrome respiratoire aigu sévère ()</term><term>Syndrome respiratoire aigu sévère (diagnostic)</term><term>Syndrome respiratoire aigu sévère (transmission)</term><term>Syndrome respiratoire aigu sévère (épidémiologie)</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Algorithms</term><term>Humans</term><term>Infection Control</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Algorithmes</term><term>Humains</term><term>Lutte contre l'infection</term><term>Syndrome respiratoire aigu sévère</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) is a newly emerged infection that is caused by a previously unrecognized virus - a novel coronavirus designated as SARS-associated coronavirus (SARS-CoV). From November 2002 to July 2003 the cumulative number of worldwide cases was >8000, with a mortality rate of close to 10%. The mortality has been higher in older patients and those with co-morbidities. SARS has been defined using clinical and epidemiological criteria and cases are considered laboratory-confirmed if SARS coronavirus is isolated, if antibody to SARS coronavirus is detected, or a polymerase chain reaction test by appropriate criteria is positive. At the time of writing (24 May 2004), no specific therapy has been recommended. A variety of treatments have been attempted, but there are no controlled data. Most patients have been treated throughout the illness with broad-spectrum antimicrobials, supplemental oxygen, intravenous fluids, and other supportive measures. Transmission of SARS is facilitated by close contact with patients with symptomatic infection. The majority of cases have been reported among healthcare providers and family members of SARS patients. Since SARS-CoV is contagious, measures for prevention center on avoidance of exposure, and infection control strategies for suspected cases and contacts. This includes standard precautions (hand hygiene), contact precautions (gowns, goggles, gloves) and airborne precautions (negative pressure rooms and high efficiency masks). In light of reports of new cases identified during the winter of 2003-4 in China, it seems possible that SARS will be an important cause of pneumonia in the future, and the screening of outpatients at risk for SARS may become part of the pneumonia evaluation.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Ohio</li></region></list><tree><noCountry><name sortKey="Tsang, Kenneth W T" sort="Tsang, Kenneth W T" uniqKey="Tsang K" first="Kenneth W T" last="Tsang">Kenneth W T. Tsang</name></noCountry><country name="États-Unis"><region name="Ohio"><name sortKey="File, Thomas M" sort="File, Thomas M" uniqKey="File T" first="Thomas M" last="File">Thomas M. File</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004627 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004627 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:15813661
|texte= Severe acute respiratory syndrome: pertinent clinical characteristics and therapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15813661" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |